Cancer studies have investigated roles and functions of these two CSC markers separately in tumor progression, invasiveness and metastases so that high expression of SALL4 and low expression of ALDH1A1 are associated with advanced levels of the disease [14, 58]. Here, SALL4 is linked to cancer.